Praxis Precision Medicines, Inc. (PRAX) stock
PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$305.06−5.21 (-1.68%)
Close on Nov 17, 2026Market cap $8.52BP/E –Yield –
Praxis Precision Medicines price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Praxis Precision Medicines's price to sales ratio was 143.6× on Sep 30, 2025, against 219.2× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Sep 30, 2025 | 143.6× | −205.0 |
| 2024 | Jul 31, 2024 | 348.6× | +249.7 |
| 2023 | Dec 29, 2023 | 98.8× | – |
See a number that looks wrong?